AbCellera Biologics Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq 2834 www.abcellera.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc.

AbCellera (ABCL) Stock May Look Fully Priced On Book Value - Nov 5th, 2026 8:21 pm
Janux Therapeutics, Inc. (JANX) Reports Q3 Loss, Beats Revenue Estimates - Nov 5th, 2026 2:10 pm
AbCellera to Present at the UBS Global Biopharma Conference on November 17, 2026 - Nov 5th, 2026 2:05 pm
Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Misses Revenue Estimates - Nov 4th, 2026 4:45 pm
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates - Nov 3rd, 2026 4:55 pm
AbCellera to Present at Upcoming Investor Conferences in November 2026 - Oct 22nd, 2026 2:05 pm
Nurix Therapeutics, Inc. (NRIX) Q3 Earnings and Revenues Surpass Estimates - Oct 12th, 2026 2:25 pm
AbCellera Biologics (ABCL) Could Be 27% Undervalued As ABCL635 Data Draws Focus - Oct 9th, 2026 5:10 pm
What Could Go Wrong With Recursion Pharmaceuticals Stock? - Oct 8th, 2026 5:58 pm
AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting - Oct 8th, 2026 2:05 pm
AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026 - Oct 1st, 2026 2:05 pm
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment - Oct 1st, 2026 10:11 am
Vasomotor Symptoms Market Poised for Growth Through 2036, Driven by Rising Adoption of Hormonal and Non-Hormonal Therapies | DelveInsight - Sep 30th, 2026 8:31 am
Why Did IOVA, ABCL, CRWD Stocks Surge To 52-Week Highs Today? - Sep 29th, 2026 8:57 pm
ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know - Sep 22nd, 2026 8:17 am
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026 - Sep 16th, 2026 2:05 pm
AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026 - Sep 2nd, 2026 2:05 pm
AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity - Aug 15th, 2026 7:09 pm
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough? - Aug 14th, 2026 4:53 pm
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants - Aug 12th, 2026 10:05 pm